Silexion Therapeutics Ltd.SLXNNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+92.5%
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+92.5%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
7.1x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2024$6.73M+625.3%
2023$928000.00+60.8%
2022$577000.00-38.9%
2021$943933.00+381.9%
2020$195860.00-